7/30/2019 SPIPA

1/1

Record 1 of 15 - IPA 1970-3/95

TI: Considerations for treatment planningAU: Weber-SSAD: Washington State University-Spokane, 601 West First Avenue, Spokane, WA 99204, USASO: ASHP-Midyear-Clinical-Meeting; 1994; 29(Dec); PI-103PY: 1994PT: Abstract of Meeting PresentationLA: EnglishAB: This presentation is designed to provide an overview of several factors which are important to consider when planning patient specific treatment. These factors include the patient's subjective need for treatment urgency, the patient's personal and family history, the patient's frequency and severity of attacks, thepatient's concurrent medical conditions, the patient's concurrent medications,the patient's co-morbid psychiatric conditions, the patient's attitude toward medication, the patient's use of OTC medications and substances of abuse, and theamount of lifestyle disruption the patient can tolerate. Learning objectives: 1. List three patient specific factors which should be considered before recommending a specific medication to manage panic attacks, 2. List three OTC agents which may modify the nature of panic attacks, 3. Describe how a medication's side effect profile can be used to guide pharmacotherapeutic choices. Self-assessmentquestions: 1. Nasal sprays and diet pills may trigger or exacerbate panic attacks. A. True or B. False; 2. Agents such as clonidine and caffeine may evoke pani

c attacks in susceptible people. A. True or B. False. 3. Antidepressants have arapid onset of action with immediate reduction of panic symptoms, whereas benzodiazepines require 3 to 6 weeks to achieve therapeutic effect. A. True or B. False. Answers: 1. (A), 2. (A), 3. (B).DE: ASHP-meeting-abstracts-panic-disorders; Panic-disorders-therapy; Toxicity-drugs; Patient-information-profileSC: 11 (Pharmacology); 6 (Drug-Evaluations)AN: 31-12007UD: 9411

Record 3 of 15 - IPA 1970-3/95

TI: Diet pills dilemmaAU: Joughin-JSO: Pharm-Cosmet-Rev (Pharmaceutical-and-Cosmetic-Review); 1991; 18(Sep-Oct); 15, 17, 19-20IS: 0257-2028PY: 1991CP: South AfricaLA: EnglishAB: The views of many retail pharmacists interviewed regarding the abuse of over-the-counter appetite suppressants are discussed and manufacturers and drug abuse experts also express their opinions.DE: Pharmacists,-community-attitudes; Anorexics-abuse; Drug-abuse-anorexics; Drugs,-over-the-counter-anorexics; Manufacturers-attitudes

PC: Anorexics (28:20)SC: 22 (Sociology-Economics-and-Ethics)AN: 29-05627UD: 9205